Is a 412‑Hz ultrasound effective for improving penile blood flow in erectile dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

412 Hz Ultrasound for Penile Blood Flow: Not Recommended

There is no evidence supporting the use of 412 Hz ultrasound for improving penile blood flow in erectile dysfunction, and this specific frequency is not mentioned in any current guidelines or research literature. The frequency you're asking about appears to be a misunderstanding or misrepresentation of actual therapeutic ultrasound modalities used in ED treatment.

What the Evidence Actually Shows

Low-Intensity Pulsed Ultrasound (LIPUS) - The Real Treatment

The confusion likely stems from low-intensity pulsed ultrasound (LIPUS), which operates at entirely different parameters and has demonstrated efficacy in clinical trials:

  • LIPUS has shown effectiveness for mild-to-moderate vasculogenic ED with response rates of 67.5% vs 20% in sham controls 1
  • Treatment protocol: Applied to penis shaft and crus for 5 minutes per area, twice weekly for 4 weeks (16 total sessions) 1, 2
  • No treatment-related adverse events were reported in large trials 1, 2
  • Results showed IIEF-5 score improvements of 3.9-4.7 points from baseline at 6 months 2

Current Guideline Position

The 2025 EAU guidelines recommend low-intensity shockwave therapy (LI-SWT) - not ultrasound - may be used in men with mild vasculogenic ED (weak recommendation) 3. The guidelines note:

  • LI-SWT showed benefit in PDE5I nonresponders 3
  • Combination with daily tadalafil or VEDs enhanced results 3
  • A standardized treatment protocol is still lacking 3

The 2018 AUA guidelines do not mention ultrasound therapy at all 4.

Critical Distinction: Ultrasound vs Shockwave

These are fundamentally different modalities:

  • LIPUS: Uses continuous or pulsed ultrasound waves for tissue stimulation
  • LI-SWT: Uses acoustic shockwaves (different physical mechanism)
  • 412 Hz: This frequency is far too low for therapeutic ultrasound (typical medical ultrasound operates at kilohertz to megahertz ranges)

What You Should Actually Offer

For mild-to-moderate vasculogenic ED, the evidence-based treatment hierarchy is:

  1. First-line: PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) - Strong recommendation 3, 4

    • Titrate dose to optimal efficacy
    • Ensure proper timing and sexual stimulation education
  2. Second-line options:

    • Intracavernosal injections (alprostadil) 3, 4
    • Vacuum erection devices 3, 4
    • Consider LIPUS (if available) for mild-moderate vasculogenic ED 1, 2
  3. Third-line: Penile prosthesis for refractory cases 3, 4

Common Pitfall

Beware of unvalidated devices claiming specific frequencies like "412 Hz" for ED treatment. This appears to be either:

  • A marketing claim without scientific basis
  • Confusion with validated LIPUS protocols
  • Misrepresentation of diagnostic Doppler ultrasound (which uses MHz frequencies for imaging, not therapy)

If a patient presents asking about "412 Hz ultrasound," redirect them to evidence-based LIPUS protocols if appropriate, or more established first-line PDE5 inhibitor therapy 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.